Merck KGaA
XETRA:MRK
Merck KGaA
XETRA:MRK
Price:
165.65 EUR
4.64%
Market Closed
Updated:
May 15, 2024
Merck KGaA
EPS (Diluted)
|
Merck KGaA
EPS (Diluted) Peer Comparison
Comparables:
ATAI
BAYN
93M1
DMP
PSG
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Merck KGaA
XETRA:MRK
|
EPS (Diluted)
€6
|
CAGR 3-Years
12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
9%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
EPS (Diluted)
$0
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
EPS (Diluted)
-€2
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MPH Health Care AG
XETRA:93M1
|
EPS (Diluted)
€6
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
EPS (Diluted)
€1
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
EPS (Diluted)
€1
|
CAGR 3-Years
-10%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Merck KGaA's EPS (Diluted)?
EPS (Diluted)
6.5
EUR
6.5
EUR
Based on the financial report for Dec 31, 2023, Merck KGaA's EPS (Diluted) amounts to 6.5 EUR.
What is Merck KGaA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
9%
9%
Over the last year, the EPS (Diluted) growth was -15%. The average annual EPS (Diluted) growth rates for Merck KGaA have been 12% over the past three years , -3% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
